China Medical Technologies Inc is NASDAQ-listed (NASDAQ:CMED). The company's production and business are currently operated by Beijing Yuande Biomedical Engineering Co Ltd, which is its wholly-owned subsidiary in China. The company was established in 1999 with headquarters and its modern factory in the Beijing Economical-Technological Development Area. The company passed the ISO9001 International Quality Management System in 2001.

Through many years of research in chemiluminescence marking analysis technology, the company took the lead in mastering the core technology. In the year 2004, the company released its enhanced chemiluminescence immunoassay system and reagent to the market, becoming the first in China to own testing facilities and manufacturing platforms and to conduct reagent research and development.

The company has a modernized factory, in which the enhanced chemiluminescence immunoassay analyzing apparatus and reagent are produced and the research and development for new products are carried out. The company adopts advanced international management methods, and has a group of professionals in management and business. It has established a distribution and service network covering the whole country. Its continual technological innovation, strict quality monitoring and sound after-sale service form the core competitiveness of the company.